Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02179073
Other study ID # 2007-02
Secondary ID
Status Completed
Phase
First received
Last updated
Start date December 2007
Est. completion date November 14, 2019

Study information

Verified date November 2019
Source Swiss Paraplegic Centre Nottwil
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Bladder management has a major impact on the quality of life in patients with neurogenic bladder dysfunction. This a prospective investigation of the effects of the method for bladder evacuation on the health-related quality of life in patients with neurogenic bladder dysfunction. The changes in health-related quality of life over time (longitudinal investigation) and the differences between the different methods for bladder evacuation will be investigated. Patients will be given a standardized and validated questionnaire annually for 10 years.


Recruitment information / eligibility

Status Completed
Enrollment 87
Est. completion date November 14, 2019
Est. primary completion date October 31, 2019
Accepts healthy volunteers No
Gender All
Age group 18 Years and older
Eligibility Inclusion Criteria:

- Individuals with neurogenic bladder dysfunction

Exclusion Criteria:

- Insufficient dexterity to fill in the questionnaire

- Insufficient proficiency in the German or French language

Study Design


Locations

Country Name City State
Switzerland Swiss Paraplegic Centre Nottwil LU

Sponsors (1)

Lead Sponsor Collaborator
Swiss Paraplegic Centre Nottwil

Country where clinical trial is conducted

Switzerland, 

Outcome

Type Measure Description Time frame Safety issue
Primary quality of life Qualiveen questionnaire up to year 10
Secondary bladder evacuation method method for bladder evacuation (i.e. intermittent catheterization, condom urinal, reflex micturition, transurethral catheter, suprapubic catheter, sacral bladder stimulator, neuromodulation) year 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Secondary urinary tract infections number of annual symptomatic urinary tract infections year 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
Secondary patient characteristics gender, age, type of neurogenic bladder dysfunction, duration of neurogenic bladder dysfunction time 0
See also
  Status Clinical Trial Phase
Terminated NCT02859844 - Transcutaneous Tibial Nerve Stimulation for Treating Neurogenic Lower Urinary Tract Dysfunction N/A
Completed NCT04528784 - Feasibility Study of Transcutaneous Tibial Nerve Stimulation for Urinary Symptoms in People With Multiple Sclerosis N/A
Completed NCT03472599 - Chronic Electrical Stimulation to Reduce Bladder Hyperreflexia N/A
Active, not recruiting NCT06333886 - Use of Point-of-care Neuro-sacral Electrophysiology Following Spinal Cord Injury
Recruiting NCT04315142 - Bladder and TranscUtaneous Tibial Nerve Stimulation for nEurogenic Lower Urinary Tract Dysfunction N/A
Enrolling by invitation NCT05312138 - Multiple Sclerosis and Overactive Bladder Treatment N/A
Active, not recruiting NCT05502614 - Dorsal Genital Nerve Stimulation for Bladder Management After SCI N/A
Recruiting NCT05681936 - Functional and Structural Changes in the Central Nervous System Following Spinal Cord Injury